Listing analysis and research matching Roche:
Biopharmaceutical partnering in China
Multinational pharmaceutical companies are increasingly investing in China through alliances and the building of new centres. Much of the investment is to supplement rather than replace the research and development already occurring outside China and is focused on development and processes than be easily codified and regulated.
BioPartnering 2008
The terms of a deal on offer, a partner's development expertise and their alliance management skills are the top drivers of alliance formation according to senior partnering business development executives in the pharmaceutical, biotechnology and medical devices industry and research institutes who participated in the BioPartnering 2008 survey.
